Tianmin Xu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 6
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 5
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 7
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 6
- Molecular Biology top 5%
- Circular RNAs in diseases 7
- Ginseng Biological Effects and Applications 6
-
- Hepatitis B Virus Studies 5
- Co-authors
- Manhua CuiShuying WuLin ChengYuan XueCong ChenZhen ZhuHuiyan ChengLi Fu
In The Last Decade
Tianmin Xu
91 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 623
- Infectious Diseases 492
- Reproductive Medicine 181
- Obstetrics and Gynecology 153
- Molecular Biology 1.3k
Countries citing papers authored by Tianmin Xu
This map shows the geographic impact of Tianmin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianmin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianmin Xu more than expected).
Fields of papers citing papers by Tianmin Xu
This network shows the impact of papers produced by Tianmin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianmin Xu. The network helps show where Tianmin Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tianmin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 19 | |
| 6 | 2023 | 25 | |
| 7 | 2021 | 19 | |
| 8 | 2020 | 41 | |
| 9 | 2020 | 78 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 28 | |
| 12 | 2019 | 40 | |
| 13 | 2018 | 4 | |
| 14 | 2018 | 40 | |
| 15 | 2018 | 21 | |
| 16 | 2017 | 156 | |
| 17 | 2017 | 61 | |
| 18 | 2013 | 1 | |
| 19 | 2012 | 4 | |
| 20 | 2007 | 74 |
About Tianmin Xu
Tianmin Xu is a scholar working on Cancer Research, Obstetrics and Gynecology and Reproductive Medicine, having authored 96 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), Ovarian cancer diagnosis and treatment (7 papers), Circular RNAs in diseases (7 papers), Ginseng Biological Effects and Applications (6 papers), MicroRNA in disease regulation (6 papers), Endometrial and Cervical Cancer Treatments (6 papers), COVID-19 Clinical Research Studies (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Cancer Research (623 citations), Infectious Diseases (492 citations) and Reproductive Medicine (181 citations). Tianmin Xu has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Manhua Cui, Manhua Cui, Shuying Wu, Lin Cheng, Yuan Xue, Cong Chen, Zhen Zhu, Huiyan Cheng, Li Fu and Jiaxing He. Their work appears in journals such as Biomedicine & Pharmacotherapy, Frontiers in Oncology, Frontiers in Genetics, International Journal of Oncology and Journal of Ovarian Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.